Moczygemba and Wash Earn 2022 Kloesel Grant

A woman and a man smiling.
January 11, 2022
Leticia "Tish" Moczygemba, Pharm.D., Ph.D. and Andrew Wash, Pharm.D. were selected as the recipients of the 2022 grant award from the Arlyn Kloesel Endowment for Excellence in Pharmacy Practice.

Research Provides Further Insight into Causes of Manganese-Induced Parkinsonism

A man smiling in a research lab.
September 7, 2021
Somshuvra Mukhopadhyay, M.B.B.S., Ph.D., associate professor in the Division of Pharmacology and Toxicology and Hamm Centennial Fellow in Pharmacy, and a team of researchers have released new findings defining the first homeostatic regulatory pathway for manganese in mammalian systems. Identifying these pathways opens up new possible options to prevent or treat manganese-induced parkinsonism and other disorders linked to elevated manganese exposure.

Vasquez Appears on BBC World Service to Discuss Z-DNA

DNA.
June 16, 2021
Division Head and Professor of Pharmacology and Toxicology Karen Vasquez, Ph.D. appeared on BBC World Service's Science in Action to talk about Z-DNA. Dr. Vasquez's research focuses on DNA damage and repair, genomic instability, gene targeting, DNA structure and cancer therapeutics.

Kompella Receives Fulbright Award for Postdoctoral Research

A woman smiling.
March 16, 2021
Division of Pharmacology and Toxicology researcher Pallavi Kompella, Ph.D. has received a Fulbright U.S. Scholar Program award to research at the Biomedical Research Institute of Málaga in Spain.

Mukhopadhyay Wins Research Excellence Award

A man standing in a research laboratory.
September 10, 2020
Associate Professor Somshuvra Mukhopadhyay, M.B.B.S., Ph.D. wins the 2020 Co-op Research Excellence Award for Best Paper. The awards are presented each year by the Office of the Vice President for Research and the University Co-operative Society.

Existing drug may help fight against the lethality of E. coli infection

Som figure
June 26, 2019
New research from the lab of Division of Pharmacology and Toxicology’s Somshuvra Mukhopadhyay, M.B.B.S., Ph.D. may have discovered a way to repurpose an existing drug to fight the lethality of Shiga toxin-producing Escherichia coli (STEC) infections.